Discovery of a highly potent, orally active mitosis/angiogenesis inhibitor r1530 for the treatment of solid tumors.
ACS Med Chem Lett
; 4(2): 259-63, 2013 Feb 14.
Article
en En
| MEDLINE
| ID: mdl-24900658
ABSTRACT
A new series of 7,8-disubstituted pyrazolobenzodiazepines based on the lead compound 1 have been synthesized and evaluated for their effects on mitosis and angiogenesis. Described herein is the design, synthesis, SAR, and antitumor activity of these compounds leading to the identification of R1530, which was selected for clinical evaluation.
Texto completo:
1
Banco de datos:
MEDLINE
Idioma:
En
Año:
2013
Tipo del documento:
Article